...
首页> 外文期刊>AIDS >Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study
【24h】

Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study

机译:初次感染抗逆转录病毒的成年人的骨质流失是否与慢性炎症有关?一项为期48周的队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE:: Antiretroviral therapy (ART) has been implicated in bone loss in HIV. The role of inflammation and vitamin D is unclear and better investigated in ART-naive individuals. DESIGN AND METHODS:: This is a 48-week, prospective cohort study to compare baseline and change in hip and spine bone mineral density (BMD) measured by dual-energy X-ray absorptiometry in HIV-infected, ART-naive adults and healthy controls matched by age, sex, and race. We also studied associations between bone loss and inflammation markers and plasma 25-hydroxyvitamin D [25(OH)D] using logistic regression. RESULTS:: Forty-seven HIV-infected adults and 41 controls were included. Baseline 25(OH)D, BMD at total hip, trochanter, and spine, and prevalence of osteopenia and osteoporosis were similar between groups. In the HIV-infected group, total hip and trochanter, but not spine, BMD decreased over 48 weeks [hip-0.005 (-0.026-0.008) g/cm, P=0.02 within group; trochanter-0.013 (-0.03-0.003), P<0.01]. BMD did not change at any site within controls. The HIV-infected group was more likely to have bone loss at the trochanter (P=0.03). This risk persisted after adjustment for age, sex, race, BMI, smoking, and hepatitis C (odds ratio 4, 95% confidence interval 1.2-15.8). In the HIV-infected group, higher interleukin-6 concentrations (P=0.04) and Caucasian race (P<0.01) were independently associated with progression to osteopenia or osteoporosis, but not 25(OH)D levels. CONCLUSION:: BMD at the total hip and trochanter sites decreased in the HIV-infected, ART-naive adults, but not controls, over this 48-week study. Higher serum interleukin-6 concentrations were associated with progression to osteopenia or osteoporosis status in the HIV-infected group.
机译:目的:抗逆转录病毒疗法(ART)与HIV的骨质流失有关。炎症和维生素D的作用尚不清楚,在未接受ART治疗的个体中进行了更好的研究。设计与方法::这是一项为期48周的前瞻性队列研究,旨在比较在HIV感染,未接受ART治疗的成年人和健康人群中通过双能X射线吸收法测量的基线和髋部和脊柱骨矿物质密度(BMD)的变化根据年龄,性别和种族匹配的控件。我们还使用逻辑回归研究了骨丢失和炎症标志物与血浆25-羟基维生素D [25(OH)D]之间的关联。结果:包括47名HIV感染的成年人和41名对照。两组之间的基线25(OH)D,全髋,大转子和脊柱的BMD以及骨质减少和骨质疏松的患病率相似。在HIV感染组中,全髋关节和转子,而非脊柱,BMD在48周内下降[hip-0.005(-0.026-0.008)g / cm,组内P = 0.02;转子-0.013(-0.03-0.003),P <0.01]。 BMD在控件内的任何位置均未更改。感染艾滋病毒的人群更可能在转子上出现骨质流失(P = 0.03)。在调整了年龄,性别,种族,BMI,吸烟和丙型肝炎之后,这种风险仍然存在(赔率4,95%的置信区间1.2-15.8)。在HIV感染组中,较高的白介素6浓度(P = 0.04)和白种人(P <0.01)与骨质减少或骨质疏松的进展独立相关,但与25(OH)D水平无关。结论:在这项为期48周的研究中,HIV感染,未接受ART治疗的成年人的髋部和转子总部位的BMD降低了,但对照组没有降低。在HIV感染组中,较高的血清白介素6浓度与骨质减少或骨质疏松状态的进展有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号